Amicus Therapeutics’ Galafold (migalastat) is the first oral treatment for the disease, and represents a rival to established enzyme replacement therapies (ERT), namely Genzyme’s Fabrazyme and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback